EUVIMEDScopri EUVIMED
Open access · CC BY-NC-ND 4.0

Rapid Serological Detection of Anti‐ GM ‐ CSF Autoantibodies in Autoimmune Pulmonary Alveolar Proteinosis Using a Novel Immunochromatographic Test

Chika Narita, Kenjiro Shima, Jun-Ichiro Sekiguchi, Yasuyuki Ozeki, Makoto Akiwa, Shohei Koike, Sachiko Yuki, Keiichi Akasaka, Toshiaki Kikuchi iD, Nobutaka Kitamura, Koh Nakata iD

Respirology · 2026

DOI: 10.1002/resp.70137 ↗

At a glance

Journal article in Respirology, 2026. Written by Chika Narita and 10 co-authors. Institution: Microbiology Research Division, Kohjin Bio Co. Ltd., Saitama, Japan. Major MEDLINE topics: Pulmonary Alveolar Proteinosis, Autoantibodies, Granulocyte-Macrophage Colony-Stimulating Factor, Autoimmune Diseases. Cited 5 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Japan Agency for Medical Research and Development.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background and Objectives Anti‐GM‐CSF autoantibodies (GMAbs) are essential biomarkers for diagnosing autoimmune pulmonary alveolar proteinosis (APAP). While enzyme‐linked immunosorbent assay (ELISA) is commonly used, it is time‐consuming and requires specialised equipment. We developed a novel immunochromatographic test (ICT) for rapid detection of GMAbs in clinical settings.

Methods

ICT was designed using a gold colloid aggregation method. The test line intensity was calibrated to be close to the ELISA cutoff of 1.65 U/mL using polyclonal anti‐GM‐CSF antibodies purified from the pooled patient sera. Validation was performed in 211 APAP and 171 non‐APAP cases. The sensitivity, specificity, and correlation with ELISA were assessed.

Results

Using known concentrations of serum from APAP patients, the grey zone concentration, which was difficult to judge by visual inspection, was found to be below 3.5 U/mL. In serological diagnosis of 211 cases with APAP and 171 cases with non‐APAP lung diseases, the sensitivity and specificity by five examiners were 100% and 98.8%, respectively. When the GMAbs positive serum was serially diluted, the end point dilution titre showed a strong correlation overall (ρ = 0.93) with the antibody concentration determined by the conventional ELISA method, but the correlation was weaker in the low concentration range below 60 U/mL (ρ = 0.67), suggesting that the accuracy of ICT was reduced in the lower concentration range.

Conclusion

This ICT offers a practical alternative to ELISA for APAP serological diagnosis. It enables rapid testing in clinical settings and supports the implementation of GM‐CSF inhalation therapy. image

Subjects

MeSH terms (MEDLINE)

Pulmonary Alveolar ProteinosisAutoantibodiesGranulocyte-Macrophage Colony-Stimulating FactorAutoimmune DiseasesChromatography, AffinityHumansSensitivity and SpecificityEnzyme-Linked Immunosorbent AssayMaleFemaleMiddle AgedBiomarkersAdult

Author keywords

autoimmune pulmonary alveolar proteinosisgranulocyte‐macrophage colony‐stimulating factorimmunochromatographic assay testserological diagnosis

Substances

AutoantibodiesGranulocyte-Macrophage Colony-Stimulating FactorBiomarkers

Authors and institutions

  • Microbiology Research Division, Kohjin Bio Co. Ltd., Saitama, Japan.
  • Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Quality Assurance Division, Kohjin Bio Co. Ltd., Saitama, Japan.
  • Division of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Department of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, Japan.
  • GM-CSF Inhalation Promoting Organization, Tokyo, Japan.

ORCID profiles: Toshiaki Kikuchi, Koh Nakata

Funding

  • Japan Agency for Medical Research and Development

Cite

APA

Narita, C., Shima, K., Sekiguchi, J. I., Ozeki, Y., Akiwa, M., Koike, S., Yuki, S., Akasaka, K., Kikuchi, T., Kitamura, N., & Nakata, K. (2026). Rapid Serological Detection of Anti‐ GM ‐ CSF Autoantibodies in Autoimmune Pulmonary Alveolar Proteinosis Using a Novel Immunochromatographic Test. Respirology. https://doi.org/10.1002/resp.70137

Vancouver

Narita C, Shima K, Sekiguchi JI, Ozeki Y, Akiwa M, Koike S, et al. Rapid Serological Detection of Anti‐ GM ‐ CSF Autoantibodies in Autoimmune Pulmonary Alveolar Proteinosis Using a Novel Immunochromatographic Test. Respirology. 2026. doi:10.1002/resp.70137

BibTeX
@article{Narita2026,
  author = {Narita, Chika and Shima, Kenjiro and Sekiguchi, Jun-Ichiro and Ozeki, Yasuyuki and Akiwa, Makoto and Koike, Shohei and Yuki, Sachiko and Akasaka, Keiichi and Kikuchi, Toshiaki and Kitamura, Nobutaka and Nakata, Koh},
  title = {Rapid Serological Detection of Anti‐ GM ‐ CSF Autoantibodies in Autoimmune Pulmonary Alveolar Proteinosis Using a Novel Immunochromatographic Test},
  journal = {Respirology},
  year = {2026},
  doi = {10.1002/resp.70137}
}
Start for free →